Hypoxia and renal fibrosis

Area of Science:

• Nephrology
• Pathophysiology
• Molecular Biology

Background:

• Renal fibrosis is a critical endpoint for progressive kidney diseases, leading to chronic kidney disease (CKD) with high mortality.
• Inflammation and metabolic stress are known modulators of kidney fibrosis.
• Hypoxia is increasingly recognized as a key factor in renal fibrosis pathogenesis, affecting oxygen sensing and cellular responses within the kidney.

Purpose of the Study:

• To review the existing literature on the impact of hypoxia on the development and progression of renal fibrosis.
• To highlight the importance of oxygen sensing in kidney health and disease.
• To explore the cell type-specific effects of hypoxia in renal fibrosis.

Main Methods:

• Literature review of existing research on hypoxia and renal fibrosis.
• Analysis of studies investigating hypoxia-inducible factors (HIFs) in kidney disease models.
• Consideration of recent advances in sequencing technologies for human studies.

Main Results:

• Hypoxia is present in various kidney diseases and affects multiple kidney cell types.
• Hypoxia-inducible factors 1 and 2 (HIF-1 and HIF-2) exhibit both pro- and antifibrotic effects.
• Dysregulated oxygen sensing, such as impaired erythropoietin production in fibrotic kidneys, exemplifies hypoxia's role.

Conclusions:

• Hypoxia plays a complex role in renal fibrosis, with both beneficial and detrimental effects depending on context.
• Cell type-specific responses to hypoxia are critical for understanding fibrosis progression.
• Further research, particularly utilizing advanced sequencing in human studies, is needed to fully elucidate hypoxia's role in renal fibrosis.